Conference Proceedings

NIVORAD: A randomised phase 2 trial of nivolumab and stereotactic ablative body radiotherapy (SABR) in advanced non-small cell lung cancer (NSCLC), progressing after first- or second-line chemotherapy

Paul Mitchell, Shankar Siva, Antony Mersiades, Ken O'Byrne, Sarah Chinchen, Chris Brown, Sonia Yip, Martin R Stockler

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | WILEY | Published : 2018